August 15, 2025 · Form 4 insider transaction
Bohnen Shane sold 50 shares of Bio-Techne Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.; 49 restricted stock units vest on 8/15/2026.